Clinical Trials Logo

Clinical Trial Summary

The objective of this study was to investigate the efficacy and safety of traditional Chinese medicine (Jueling Mingmu Decoction) combined with ranibizumab in the treatment of macular edema with retinal vein obstructive.


Clinical Trial Description

Compared to the sole intravitreal injection of ranibizumab, the combined use of traditional Chinese medicine with intravitreal ranibizumab aims to determine if it is more effective in alleviating macular cystoid edema secondary to retinal branch vein occlusion, leading to improved visual prognosis and potentially reducing the frequency of intravitreal drug injections. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06234514
Study type Interventional
Source Dongyang People's Hospital
Contact Hongyan Wu
Phone +13967490168
Email hongyanwu1982@163.com
Status Recruiting
Phase Phase 4
Start date January 1, 2023
Completion date December 31, 2024